Compounds > 8-tert-butyl-6,7-dihydropyrrolo(3,2-e)-5-methylpyrazolo(1,5-a)pyrimidine-3-carbonitrile
Page last updated: 2024-09-05

8-tert-butyl-6,7-dihydropyrrolo(3,2-e)-5-methylpyrazolo(1,5-a)pyrimidine-3-carbonitrile and Coronary Disease

8-tert-butyl-6,7-dihydropyrrolo(3,2-e)-5-methylpyrazolo(1,5-a)pyrimidine-3-carbonitrile has been researched along with Coronary Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abiko, Y; Ichihara, K; Morimoto, T; Shiba, T; Tsujitani, M1

Other Studies

1 other study(ies) available for 8-tert-butyl-6,7-dihydropyrrolo(3,2-e)-5-methylpyrazolo(1,5-a)pyrimidine-3-carbonitrile and Coronary Disease

ArticleYear
Attenuation of ischemia-induced regional myocardial acidosis by LP-805, a newly developed vasodilator, in dogs.
    European journal of pharmacology, 1991, Nov-05, Volume: 204, Issue:2

    Topics: Acidosis; Animals; Blood Pressure; Coronary Circulation; Coronary Disease; Dogs; Female; Heart Rate; Hydrogen-Ion Concentration; Male; Myocardium; Pyrazoles; Pyrimidines; Vasodilator Agents

1991